highlight
use
sarscov
receptor
host
cell
entri
spike
protein
prime
antibodi
sarscov
spike
may
offer
protect
emerg
sarscoronaviru
threaten
public
health
hoffmann
cowork
show
infect
depend
host
cell
factor
block
clinic
proven
proteas
inhibitor
find
might
help
establish
option
prevent
treatment
sever
member
famili
coronavirida
constantli
circul
human
popul
usual
caus
mild
respiratori
diseas
corman
et
al
contrast
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
transmit
anim
human
caus
sever
respiratori
diseas
afflict
individu
sar
mer
respect
fehr
et
al
sar
emerg
guangdong
provinc
china
subsequ
global
spread
associ
case
death
de
wit
et
al
chines
horsesho
bat
serv
natur
reservoir
host
sarscov
lau
et
al
li
et
al
human
transmiss
facilit
intermedi
host
like
civet
cat
raccoon
dog
frequent
sold
food
sourc
chines
wet
market
guan
et
al
present
specif
antivir
approv
vaccin
avail
combat
sar
sar
pandem
final
stop
convent
control
measur
includ
travel
restrict
patient
isol
decemb
new
infecti
respiratori
diseas
emerg
wuhan
hubei
provinc
china
wang
et
al
zhu
et
al
initi
cluster
infect
link
huanan
seafood
market
potenti
due
anim
contact
subsequ
humantohuman
transmiss
occur
chan
et
al
diseas
term
coronaviru
diseas
rapidli
spread
within
china
novel
coronaviru
sarscoronaviru
close
relat
sarscov
detect
patient
believ
etiolog
agent
new
lung
diseas
februari
total
laboratoryconfirm
infect
report
china
includ
sever
case
death
infect
also
detect
countri
outsid
china
associ
intern
travel
present
unknown
whether
sequenc
similar
sarscov
translat
similar
biolog
properti
includ
pandem
potenti
munster
et
al
spike
protein
coronavirus
facilit
viral
entri
target
cell
entri
depend
bind
surfac
unit
protein
cellular
receptor
facilit
viral
attach
surfac
target
cell
addit
entri
requir
protein
prime
cellular
proteas
entail
protein
cleavag
site
allow
fusion
viral
cellular
membran
process
driven
subunit
figur
sarss
engag
angiotensinconvert
enzym
entri
receptor
employ
cellular
serin
proteas
protein
prime
glowacka
et
al
matsuyama
et
al
shulla
et
al
interfac
elucid
atom
level
effici
usag
found
key
determin
sarscov
transmiss
li
et
al
li
et
al
sarss
und
share
amino
acid
ident
howev
unknown
whether
like
sarss
employ
host
cell
entri
evid
effici
proteolyt
process
goal
studi
obtain
insight
facilit
viral
entri
target
cell
process
proteolyt
cleavag
site
amino
acid
sequenc
around
two
proteas
recognit
site
red
indic
sarss
asterisk
indic
conserv
residu
arrow
head
indic
cleavag
site
b
analysi
express
upper
panel
pseudotyp
incorpor
lower
panel
western
blot
use
antibodi
direct
ctermin
hemagglutinin
ha
tag
ad
viral
protein
analyz
shown
repres
blot
three
experi
bactin
cell
lysat
vsvm
particl
serv
load
control
matrix
protein
black
arrow
head
indic
band
correspond
uncleav
protein
wherea
gray
arrow
head
indic
band
correspond
subunit
c
cell
line
human
anim
origin
inocul
pseudotyp
vsv
harbor
vsvg
sarss
h
postinocul
pseudotyp
entri
analyz
determin
luciferas
activ
cell
lysat
signal
obtain
particl
bear
envelop
protein
use
normal
averag
three
independ
experi
shown
error
bar
indic
sem
unprocess
data
singl
experi
present
figur
block
first
ask
whether
robustli
express
human
cell
line
commonli
use
experiment
high
transfect
moreov
analyz
whether
evid
proteolyt
process
protein
certain
coronaviru
protein
cleav
host
cell
proteas
cleavag
site
infect
cell
figur
immunoblot
analysi
cell
express
protein
ctermin
antigen
tag
reveal
band
molecular
weight
expect
unprocess
protein
figur
band
size
expect
subunit
protein
also
observ
cell
promin
vesicular
stomat
viru
vsv
particl
bear
figur
contrast
signal
larg
absent
cell
particl
express
sarss
figur
previous
document
glowacka
et
al
hofmann
et
al
result
suggest
effici
proteolyt
process
human
cell
keep
presenc
sever
arginin
residu
cleavag
site
sarss
figur
contrast
cleavag
site
similar
sarss
replicationdefect
vsv
particl
bear
coronaviru
protein
faith
reflect
key
aspect
coronaviru
host
cell
entri
kleineweb
et
al
employ
vsv
pseudotyp
bear
studi
cell
entri
sarss
robustli
incorpor
vsv
particl
figur
allow
meaning
sidebysid
comparison
although
formal
compar
particl
incorpor
subunit
remain
demonstr
first
ask
cell
line
suscept
entri
use
panel
wellcharacter
cell
line
human
anim
origin
respect
cell
line
readili
suscept
entri
driven
glycoprotein
pantrop
vsv
vsvg
figur
figur
expect
human
cell
line
anim
cell
line
vero
mdckii
also
suscept
entri
driven
sarss
figur
moreov
facilit
entri
ident
spectrum
cell
line
sarss
figur
suggest
similar
choic
entri
receptor
order
elucid
sarss
mediat
entri
cell
line
next
determin
whether
harbor
amino
acid
residu
requir
interact
sarss
entri
receptor
sequenc
analysi
reveal
cluster
sarscovrel
virus
bat
sarsrcov
use
host
cell
entri
figur
figur
analysi
receptor
bind
motif
rbm
portion
receptor
bind
domain
rbd
make
contact
li
et
al
reveal
amino
acid
residu
essenti
bind
sarss
conserv
figur
contrast
residu
absent
protein
sarsrcov
previous
found
use
entri
figur
ge
et
al
hoffmann
et
al
menacheri
et
al
agreement
find
direct
express
human
bat
rhinolophu
alcyon
human
entri
receptor
use
merscov
raj
et
al
human
apn
entri
receptor
use
yeager
et
al
allow
sarssdriven
entri
otherwis
nonsuscept
cell
figur
moreov
antiserum
rais
human
block
sarssand
vsvgor
merssdriven
entri
figur
final
authent
infect
cell
transfect
express
cell
parent
cell
high
effici
figur
indic
like
sarss
use
cellular
entri
cellular
serin
proteas
prime
entri
serin
proteas
inhibitor
block
infect
lung
cell
next
investig
proteas
depend
entri
sarscov
use
endosom
cystein
proteas
cathepsin
b
l
catbl
simmon
et
al
serin
proteas
glowacka
et
al
matsuyama
et
al
shulla
et
al
protein
prime
cell
line
inhibit
proteas
requir
robust
blockad
viral
entri
kawas
et
al
howev
activ
essenti
viral
spread
pathogenesi
infect
host
wherea
catbl
activ
dispens
iwatayoshikawa
et
al
shirato
et
al
shirato
et
al
zhou
et
al
order
determin
whether
use
catbl
cell
entri
initi
employ
ammonium
chlorid
elev
endosom
ph
therebi
block
catbl
activ
cell
transfect
express
robust
proteindriven
entri
cell
use
target
ammonium
chlorid
block
vsvgdepend
entri
cell
line
wherea
entri
driven
nipah
viru
f
g
protein
affect
figur
data
shown
consist
nipah
viru
vsv
abl
fuse
directli
plasma
membran
bossart
et
al
ammonium
chlorid
treatment
strongli
inhibit
sarssdriven
entri
cell
figur
suggest
catbl
depend
inhibit
entri
cell
less
effici
compar
cell
figur
would
compat
prime
cell
inde
clinic
proven
serin
proteas
inhibitor
camostat
mesyl
activ
kawas
et
al
partial
block
entri
figur
b
cell
figur
full
inhibit
attain
camostat
mesyl
inhibitor
catbl
ad
figur
figur
indic
use
catbl
well
prime
cell
line
contrast
camostat
mesyl
interfer
entri
cell
line
figur
vero
figur
effici
block
therefor
catbl
depend
moreov
direct
express
rescu
entri
inhibit
figur
confirm
employ
protein
prime
next
analyz
whether
usag
requir
infect
lung
cell
inde
camostat
mesyl
significantli
reduc
merss
sarss
vsvgdriven
entri
lung
cell
line
figur
exert
unwant
cytotox
effect
figur
c
similarli
camostat
mesyl
treatment
significantli
reduc
infect
authent
figur
final
camostat
mesyl
treatment
inhibit
sarssand
vsvgdriven
entri
primari
human
lung
cell
figur
figur
detail
b
align
receptor
bind
motif
sarss
correspond
sequenc
batassoci
betacoronaviru
protein
abl
unabl
use
cellular
receptor
reveal
possess
crucial
amino
acid
residu
bind
collect
use
protein
prime
camostat
mesyl
inhibitor
block
infect
lung
cell
evid
antibodi
rais
sarscov
crossneutr
convalesc
sar
patient
exhibit
neutral
antibodi
respons
direct
viral
protein
liu
et
al
investig
whether
antibodi
block
entri
four
sera
obtain
three
convalesc
sar
patient
inhibit
sarssbut
vsvgdriven
entri
concentrationdepend
manner
figur
addit
sera
also
reduc
entri
although
lower
effici
compar
sarss
figur
similarli
rabbit
sera
rais
subunit
sarss
reduc
sarssand
entri
high
effici
inhibit
sarssdriven
entri
effici
thu
antibodi
respons
rais
sarss
infect
vaccin
might
offer
level
protect
infect
present
studi
provid
evid
host
cell
entri
depend
sarscov
receptor
block
clinic
proven
inhibitor
cellular
serin
proteas
employ
protein
prime
moreov
suggest
antibodi
respons
rais
sarscov
could
least
partial
protect
infect
result
import
implic
understand
transmiss
pathogenesi
reveal
target
therapeut
intervent
find
exploit
entri
also
report
zhou
colleagu
zhou
et
al
present
manuscript
revis
suggest
viru
might
target
similar
spectrum
cell
sarscov
lung
sarscov
infect
mainli
pneumocyt
macrophag
shieh
et
al
howev
express
limit
lung
extrapulmonari
spread
sarscov
tissu
observ
ding
et
al
gu
et
al
ham
et
al
expect
although
affin
sarss
remain
legend
next
page
compar
suggest
modest
express
upper
respiratori
tract
bertram
et
al
ham
et
al
might
limit
sarscov
transmiss
light
potenti
increas
transmiss
rel
sarscov
one
may
specul
new
viru
might
exploit
cellular
attachmentpromot
factor
higher
effici
sarscov
ensur
robust
infect
cell
upper
respiratori
tract
could
compris
bind
cellular
glycan
function
ascrib
domain
certain
coronavirus
li
et
al
park
et
al
final
note
express
protect
lung
injuri
downregul
sarss
haga
et
al
imai
et
al
kuba
et
al
might
promot
sar
thu
interest
determin
whether
also
interfer
express
prime
coronaviru
protein
host
cell
proteas
essenti
viral
entri
cell
encompass
protein
cleavag
site
cleavag
site
harbor
sever
arginin
residu
multibas
indic
high
cleavabl
inde
effici
cleav
cell
cleav
protein
incorpor
vsv
particl
notabl
cleavag
site
sequenc
determin
zoonot
potenti
coronavirus
menacheri
et
al
yang
et
al
yang
et
al
multibas
cleavag
site
present
coronaviru
close
relat
thu
interest
determin
whether
presenc
multibas
cleavag
site
requir
entri
human
cell
cleavag
site
acquir
protein
sarscov
use
endosom
cystein
proteas
catbl
protein
prime
cell
simmon
et
al
howev
protein
prime
catbl
essenti
viral
entri
primari
target
cell
viral
spread
infect
host
iwatayoshikawa
et
al
kawas
et
al
zhou
et
al
present
studi
indic
spread
also
depend
activ
although
note
infect
cell
inhibit
abrog
camostat
mesyl
like
reflect
residu
protein
prime
catbl
one
specul
furinmedi
precleavag
site
infect
cell
might
promot
subsequ
entri
target
cell
report
merscov
kleineweb
et
al
park
et
al
collect
present
find
previou
work
highlight
host
cell
factor
critic
spread
sever
clinic
relev
virus
includ
influenza
virus
coronavirus
gierer
et
al
glowacka
et
al
iwatayoshikawa
et
al
kawas
et
al
matsuyama
et
al
shulla
et
al
zhou
et
al
contrast
dispens
develop
homeostasi
kim
et
al
thu
constitut
attract
drug
target
context
noteworthi
serin
proteas
inhibitor
camostat
mesyl
block
activ
kawas
et
al
zhou
et
al
approv
japan
human
use
unrel
indic
compound
relat
one
potenti
increas
antivir
activ
yamamoto
et
al
could
thu
consid
offlabel
treatment
patient
convalesc
sar
patient
exhibit
neutral
antibodi
respons
detect
even
month
infect
liu
et
al
larg
direct
protein
moreov
experiment
sar
vaccin
includ
recombin
protein
et
al
inactiv
viru
lin
et
al
induc
neutral
antibodi
respons
although
confirm
infecti
viru
pend
result
indic
neutral
antibodi
respons
rais
sarss
could
offer
protect
infect
may
implic
outbreak
control
sum
studi
provid
key
insight
first
step
infect
viral
entri
cell
defin
potenti
target
antivir
intervent
detail
method
provid
onlin
version
paper
includ
follow
thank
heik
hofmannwinkl
discuss
andrea
maisner
nipah
f
g
express
plasmid
anett
teichmann
technic
assist
roberto
cattaneo
plasmid
acknowledg
support
nonprofit
foundat
htcr
hold
human
tissu
trust
make
broadli
avail
research
ethic
legal
basi
grate
acknowledg
author
origin
submit
laboratori
sequenc
metadata
share
gisaid
research
base
work
support
bmbf
rapid
consortium
cd
sp
german
research
foundat
dfg
wu
nhw
author
declar
compet
interest
receiv
februari
revis
februari
accept
februari
publish
march
pseudotyp
harbor
indic
viral
surfac
protein
incub
differ
dilut
sera
three
convalesc
sar
patient
sera
rabbit
immun
subunit
sarss
subsequ
inocul
onto
vero
cell
order
evalu
crossneutr
potenti
averag
three
independ
experi
perform
triplic
sampl
shown
error
bar
indic
sem
statist
signific
test
twoway
anova
dunnett
posttest
dipeptidylpeptidas
human
describ
elsewher
bertram
et
al
brinkmann
et
al
gierer
et
al
hoffmann
et
al
hofmann
et
al
kleineweb
et
al
gener
express
plasmid
without
ctermin
ha
epitop
tag
pcramplifi
code
sequenc
synthet
codonoptim
human
cell
dna
geneart
gene
synthesi
thermofish
scientif
base
publicli
avail
protein
sequenc
nation
center
biotechnolog
inform
databas
ncbi
refer
sequenc
clone
express
vector
via
bamhi
xbai
restrict
site
pseudotyp
vsv
pseudotyp
gener
accord
publish
protocol
berger
rentsch
zimmer
brief
transfect
express
viral
surfac
glycoprotein
studi
inocul
replicationdefici
vsv
vector
contain
express
cassett
egfp
enhanc
green
fluoresc
protein
firefli
luciferas
instead
vsvg
open
read
frame
vsv
dgfluc
kindli
provid
gert
zimmer
institut
virolog
immunolog
usernswitzerland
incub
period
h
c
inoculum
remov
cell
wash
pb
medium
supplement
antivsvg
antibodi
mous
hybridoma
supernat
atcc
ad
order
neutral
residu
input
viru
antibodi
ad
cell
express
vsvg
pseudotyp
particl
harvest
h
postinocul
clarifi
cellular
debri
centrifug
use
experiment
transduct
target
cell
grown
plate
reach
confluenc
inocul
respect
pseudotyp
vsv
experi
address
receptor
usag
cell
transfect
express
plasmid
h
transduct
order
block
cell
surfac
cell
pretreat
mgml
antibodi
r
system
goat
control
unrel
antidcsign
antibodi
serotec
goat
mgml
use
experi
involv
ammonium
chlorid
final
concentr
mm
proteas
inhibitor
mm
camostat
mesyl
mm
target
cell
treat
respect
chemic
h
transduct
neutral
experi
pseudotyp
preincub
min
c
differ
serum
dilut
transduct
effici
quantifi
h
posttransduct
measur
activ
firefli
luciferas
cell
lysat
use
commerci
substrat
beetlejuic
pjk
hidex
sens
plate
luminomet
hidex
cell
viabil
follow
treatment
cell
camostat
mesyl
analyz
use
luminesc
cell
viabil
assay
promega
brief
cell
grown
confluenc
plate
incub
h
absenc
presenc
differ
concentr
mm
camostat
mesyl
next
cultur
medium
aspir
ml
fresh
cultur
medium
ad
ident
volum
assay
substrat
ad
well
contain
cultur
medium
serv
control
determin
assay
background
min
incub
rock
platform
addit
min
without
movement
sampl
transfer
white
opaquewal
plate
luminesc
signal
record
use
hidex
sens
plate
luminomet
hidex
analyz
protein
express
cell
cell
transfect
express
vector
hatag
sarss
empti
express
vector
neg
control
cultur
medium
replac
h
posttransfect
cell
incub
addit
h
cultur
medium
remov
cell
wash
pb
sdssampl
buffer
trishcl
glycerol
sd
bromophenol
blue
mm
edta
ad
cell
incub
min
room
temperatur
next
sampl
heat
min
c
subject
sdspage
immunoblot
analysi
protein
incorpor
pseudotyp
particl
ml
respect
vsv
pseudotyp
load
onto
wv
sucros
cushion
volum
ml
subject
highspe
centrifug
g
min
c
thereaft
ml
supernat
remov
residu
volum
mix
ml
sdssampl
buffer
heat
min
c
subject
sdspage
immunoblot
protein
transfer
nitrocellulos
membran
block
skim
milk
solut
skim
milk
dissolv
pb
contain
pbst
h
room
temperatur
incub
night
c
primari
antibodi
dilut
skim
milk
solut
follow
three
wash
interv
min
pbst
membran
incub
h
room
temperatur
secondari
antibodi
dilut
skim
milk
solut
membran
wash
imag
use
houseprepar
enhanc
chemiluminesc
solut
trishcl
ph
mgml
luminol
mgml
parahydroxycoumar
acid
h
chemocam
imag
system
along
chemostar
profession
softwar
inta
scienc
imag
instrument
gmbh
follow
primari
antibodi
use
mous
antiha
tag
sigmaaldrich
mous
antibactin
sigmaaldrich
mous
antivsv
matrix
protein
kerafast
secondari
antibodi
use
peroxidasecoupl
goat
antimous
antibodi
dianova
infect
authent
cell
cellsml
transfect
dsred
neg
control
h
cell
wash
pb
infect
genom
equival
ge
per
isol
munich
h
c
cell
cellsml
mock
treat
treat
mm
camostat
mesyl
sigma
aldrich
h
prior
infect
isol
munich
multipl
infect
moi
h
c
infect
cell
wash
three
time
pb
ml
dmem
medium
ad
h
post
infect
ml
cultur
supernat
subject
viral
rna
extract
use
viral
rna
kit
machereynagel
accord
manufactur
instruct
ge
per
ml
detect
real
time
rtpcr
use
previous
report
protocol
corman
et
al
convalesc
human
antisarscov
sera
stem
serum
collect
nation
consiliari
laboratori
coronaviru
diagnost
berlin
germani
robert
koch
institut
berlin
germani
sera
previous
test
posit
use
recombin
sbase
immunofluoresc
test
buchholz
et
al
taken
sar
patient
year
post
onset
diseas
origin
second
sar
patient
day
post
onset
diseas
collect
third
sar
patient
day
post
onset
diseas
rabbit
sera
obtain
immun
rabbit
purifi
protein
fuse
fc
portion
human
immunoglobulin
phylogenet
analysi
neighborjoin
tree
bootstrap
method
iter
poisson
substitut
model
uniform
rate
among
site
complet
delet
gapsmiss
data
perform
use
softwar
refer
sequenc
obtain
nation
center
biotechnolog
inform
gisaid
global
initi
share
influenza
data
databas
refer
number
indic
figur
oneway
twoway
analysi
varianc
anova
dunnett
posttest
use
test
statist
signific
p
valu
lower
consid
statist
signific
p
ns
signific
p
p
p
statist
analys
graphpad
prism
softwar
packag
use
graphpad
softwar
studi
gener
uniqu
dataset
code
cell
april
figur
repres
experi
includ
averag
relat
figur
indic
cell
line
inocul
pseudoparticl
harbor
indic
viral
glycoprotein
harbor
glycoprotein
protein
luciferas
activ
cell
lysat
determin
h
posttransduct
experi
perform
quadrupl
sampl
averag
sd
shown
b
import
endosom
low
ph
activ
catbl
b
host
cell
entri
evalu
ad
inhibitor
target
cell
prior
transduct
ammonium
chlorid
block
endosom
acidif
camostat
mesyl
b
block
activ
catbl
respect
entri
cell
treat
inhibitor
set
c
absenc
cytotox
effect
camostat
mesyl
cell
treat
camostat
mesyl
ident
infect
experi
cell
viabil
measur
use
commerci
avail
assay
celltiterglo
promega
